Adage Capital Partners Gp, L.L.C. Uro Gen Pharma Ltd. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,735,741 shares of URGN stock, worth $43.1 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,735,741
Previous 3,300,000
13.2%
Holding current value
$43.1 Million
Previous $55.4 Million
14.32%
% of portfolio
0.09%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding URGN
# of Institutions
130Shares Held
35.9MCall Options Held
22KPut Options Held
93.8K-
Rtw Investments, LP New York, NY3.79MShares$43.7 Million0.77% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$26.6 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$25.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.18MShares$25.2 Million0.0% of portfolio
-
Cowen And Company, LLC1.8MShares$20.8 Million0.59% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $263M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...